2006
DOI: 10.1111/j.1468-2982.2006.01101.x
|View full text |Cite
|
Sign up to set email alerts
|

Chronic Paroxysmal Hemicrania in a Patient with a Macroprolactinoma

Abstract: We report a patient with headaches meeting the criteria of chronic paroxysmal hemicrania, as defined by the International Headache Society classification. Headaches were fully responsive to indomethacin during the first 3 months of treatment but recurred when daily doses were lowered. Investigations revealed a macroprolactinoma. Headaches stopped after cabergoline treatment. This report further suggests that patients with paroxysmal hemicrania should be investigated for pituitary abnormalities.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
0

Year Published

2007
2007
2019
2019

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 20 publications
(15 citation statements)
references
References 16 publications
0
15
0
Order By: Relevance
“…The most common headache syndrome observed in association with pituitary tumors is chronic migraine, often occurring in patients with previous migraine [4,[17][18][19]. There is an increased prevalence of trigeminal autonomic cephalgias (TACs) in patients with pituitary tumors compared with the general population [20•], which includes cluster headache [4,7,11,12], SUNCT (short-lasting, unilateral, neuralgiform headache attacks with conjunctival injection and tearing) [4,6,8,9], paroxysmal hemicrania [21], and hemicrania continua [6]. There are also descriptions of "trigeminal neuralgia" occurring with pituitary tumors [14][15][16]22], although some of these historical cases would probably now be classified as TACs.…”
Section: Clinical Featuresmentioning
confidence: 99%
“…The most common headache syndrome observed in association with pituitary tumors is chronic migraine, often occurring in patients with previous migraine [4,[17][18][19]. There is an increased prevalence of trigeminal autonomic cephalgias (TACs) in patients with pituitary tumors compared with the general population [20•], which includes cluster headache [4,7,11,12], SUNCT (short-lasting, unilateral, neuralgiform headache attacks with conjunctival injection and tearing) [4,6,8,9], paroxysmal hemicrania [21], and hemicrania continua [6]. There are also descriptions of "trigeminal neuralgia" occurring with pituitary tumors [14][15][16]22], although some of these historical cases would probably now be classified as TACs.…”
Section: Clinical Featuresmentioning
confidence: 99%
“…Dopamine agonists are used for the medical management of prolactinomas, but in the series reported by Levy et al [28,29]. This effect is not consistent, as others have reported chronic paroxysmal hemicrania (CPH) and cluster-like headache associated with prolactinomas responding well to dopamine agonists [30][31][32].…”
Section: Headache and Pituitary Tumorsmentioning
confidence: 99%
“…Only one of nine cases of HC and no cases (out of seven) of SUNCT were associated with tumors. Other cases of CPH have been reported in a patient with multiple cranial metastases, including one in the right cavernous sinus and in another patient with a macroprolactinoma [32,36]. SUNCT syndrome has been associated with lesions in a number of locations.…”
Section: Tacs and Other Brain Tumorsmentioning
confidence: 99%
“…There are numerous case reports of pituitary tumors presenting with the entire range of headache disorders (Table 1), including migraine [16][17][18], cluster headache [4,[19][20][21], SUNCT [5,22,23], hemicrania continua [5], paroxysmal hemicrania [6], and "trigeminal neuralgia" [8][9][10]24]. On close inspection of the literature, some of the cases labeled as trigeminal neuralgia appear to have had cranial autonomic features [24], suggesting the presence of a trigeminal autonomic cephalalgia.…”
Section: Headache Presentationsmentioning
confidence: 99%
“…Growth hormone-secreting pituitary tumors are particularly associated with headache that may be successfully aborted with somatostatin analogues [3]. Prolactinomas have been reported in association with cluster headache [4], SUNCT (shortlasting, unilateral, neuralgiform headache attacks with conjunctival injection and tearing) [5], paroxysmal hemicrania [6], and hemicrania continua [5], and the administration of dopamine agonist therapy can lead to either a dramatic improvement or exacerbation of symptoms [5]. These observations have led to the hypothesis that headache may have a biochemical basis in certain pituitary tumors.…”
Section: Introductionmentioning
confidence: 98%